Brown M

Zylorion

2 papers

ArticleKetamine

A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)

Chue P, Silverstone P, Hillier T +6

Europe PMC2023
ArticlePsilocybin

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.

Higgins GA, Carroll NK, Brown M +7

Europe PMC2021